These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 35666610

  • 1. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma.
    Fang Y, Yan D, Wang L, Zhang J, He Q.
    J Clin Lab Anal; 2022 Jul; 36(7):e24541. PubMed ID: 35666610
    [Abstract] [Full Text] [Related]

  • 2. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA.
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [Abstract] [Full Text] [Related]

  • 3. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
    Malik J, Klammer M, Rolny V, Chan HL, Piratvisuth T, Tanwandee T, Thongsawat S, Sukeepaisarnjaroen W, Esteban JI, Bes M, Köhler B, Swiatek-de Lange M.
    World J Gastroenterol; 2022 Aug 07; 28(29):3917-3933. PubMed ID: 36157551
    [Abstract] [Full Text] [Related]

  • 4. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE, Fawzy NA, El-Sheikh SM, Soliman ME.
    Mol Diagn Ther; 2015 Aug 07; 19(4):213-20. PubMed ID: 26133725
    [Abstract] [Full Text] [Related]

  • 5. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y, Zhang C, Zhang P, Guo G, Jiang T, Zhao X, Jiang J, Huang X, Tong H, Tian Y.
    Cancer Med; 2018 May 07; 7(5):1670-1679. PubMed ID: 29573235
    [Abstract] [Full Text] [Related]

  • 6. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.
    Lancet Oncol; 2015 Jul 07; 16(7):804-15. PubMed ID: 26088272
    [Abstract] [Full Text] [Related]

  • 7. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP, Abate ML, Gaia S, Petrini E, Bosco C, Olivero A, Rosso C, Ciancio A, Pellicano R, Saracco GM, Rizzetto M, Smedile A.
    Panminerva Med; 2017 Dec 07; 59(4):283-289. PubMed ID: 28650134
    [Abstract] [Full Text] [Related]

  • 8. Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
    Yu B, Zhou S, Liang H, Ye Q, Wang Y.
    Dig Dis Sci; 2022 Jun 07; 67(6):2283-2292. PubMed ID: 33982217
    [Abstract] [Full Text] [Related]

  • 9. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S, Datta S, Chowdhury A, Chatterjee R, Mohapatra SK, Banerjee S.
    Int J Cancer; 2016 Jun 01; 138(11):2732-44. PubMed ID: 26756996
    [Abstract] [Full Text] [Related]

  • 10. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S, Bhowmik S, Majumdar S, Goswami A, Chakraborty J, Gupta S, Aggarwal S, Ray S, Chatterjee R, Bhattacharyya S, Dutta M, Datta S, Chowdhury A, Dhali GK, Banerjee S.
    Int J Cancer; 2020 Nov 15; 147(10):2934-2947. PubMed ID: 32441313
    [Abstract] [Full Text] [Related]

  • 11. Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
    Fouda MS, Omran MM, Tarek G, Hady A Abdel Wahab A.
    Arab J Gastroenterol; 2021 Mar 15; 22(1):28-33. PubMed ID: 33268243
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P, Chuaypen N, Nimsamer P, Payungporn S, Pinjaroen N, Sirichindakul B, Tangkijvanich P.
    PLoS One; 2020 Mar 15; 15(4):e0232211. PubMed ID: 32330203
    [Abstract] [Full Text] [Related]

  • 13. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D, Chen L, Liu X, Wang X, Xi Q, Luo Y, Zhang N, Guo H.
    Tumour Biol; 2016 May 15; 37(5):6539-49. PubMed ID: 26637228
    [Abstract] [Full Text] [Related]

  • 14. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
    Hung CH, Hu TH, Lu SN, Kuo FY, Chen CH, Wang JH, Huang CM, Lee CM, Lin CY, Yen YH, Chiu YC.
    Int J Cancer; 2016 Feb 01; 138(3):714-20. PubMed ID: 26264553
    [Abstract] [Full Text] [Related]

  • 15. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N, Duong DC, Tong HV, Hien TTT, Hoan PQ, Bang MH, Binh MT, Ky TD, Tung NL, Thinh NT, Sang VV, Thao LTP, Bock CT, Velavan TP, Meyer CG, Song LH, Toan NL.
    PLoS One; 2018 Feb 01; 13(4):e0196081. PubMed ID: 29672637
    [Abstract] [Full Text] [Related]

  • 16. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L, Lu B, Yu J, Liu W, Zhou A.
    Clin Res Hepatol Gastroenterol; 2016 Sep 01; 40(4):397-404. PubMed ID: 26724963
    [Abstract] [Full Text] [Related]

  • 17. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT, Liu RB, Liang YY, Hasan AME, Wang HY, Shao Q, Zhang ZC, Wang J, He CY, Wang F, Shao JY.
    Liver Int; 2017 Jun 01; 37(6):888-896. PubMed ID: 28061012
    [Abstract] [Full Text] [Related]

  • 18. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L, Chu F, Cao Y, Shao J, Wang F.
    Tumour Biol; 2015 Sep 01; 36(10):7439-47. PubMed ID: 25903466
    [Abstract] [Full Text] [Related]

  • 19. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis.
    Li G, Shen Q, Li C, Li D, Chen J, He M.
    Clin Transl Oncol; 2015 Sep 01; 17(9):684-93. PubMed ID: 25956842
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma.
    El Mahdy HA, Abdelhamid IA, Amen AI, Abdelsameea E, Hassouna MM.
    Asian Pac J Cancer Prev; 2019 Sep 01; 20(9):2723-2731. PubMed ID: 31554369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.